KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Non-Current Deffered Revenue: 2009-2024

Historic Non-Current Deffered Revenue for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $26.9 million.

  • Idexx Laboratories' Non-Current Deffered Revenue rose 15.98% to $31.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.1 million, marking a year-over-year increase of 15.98%. This contributed to the annual value of $26.9 million for FY2024, which is 5.59% down from last year.
  • Latest data reveals that Idexx Laboratories reported Non-Current Deffered Revenue of $26.9 million as of FY2024, which was down 5.59% from $28.5 million recorded in FY2023.
  • Idexx Laboratories' Non-Current Deffered Revenue's 5-year high stood at $46.2 million during FY2020, with a 5-year trough of $26.9 million in FY2024.
  • For the 3-year period, Idexx Laboratories' Non-Current Deffered Revenue averaged around $28.8 million, with its median value being $28.5 million (2023).
  • Data for Idexx Laboratories' Non-Current Deffered Revenue shows a maximum YoY decreased of 25.04% (in 2022) over the last 5 years.
  • Idexx Laboratories' Non-Current Deffered Revenue (Yearly) stood at $46.2 million in 2020, then dropped by 10.81% to $41.2 million in 2021, then fell by 25.04% to $30.9 million in 2022, then decreased by 7.55% to $28.5 million in 2023, then decreased by 5.59% to $26.9 million in 2024.